Global Self-administered Parenteral Supply, Demand and Key Producers, 2024-2030
The global Self-administered Parenteral market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Self-administered Parenteral production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Self-administered Parenteral, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Self-administered Parenteral that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Self-administered Parenteral total production and demand, 2019-2030, (K Units)
Global Self-administered Parenteral total production value, 2019-2030, (USD Million)
Global Self-administered Parenteral production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-administered Parenteral consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Self-administered Parenteral domestic production, consumption, key domestic manufacturers and share
Global Self-administered Parenteral production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Self-administered Parenteral production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-administered Parenteral production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Self-administered Parenteral market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Becton, Dickinson and Company, scPharmaceuticals, Harro Hofliger, Owen Mumford, Haselmeier, Stevanato Group, Ypsomed AG, Solteam Group and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Self-administered Parenteral market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Self-administered Parenteral Market, By Region:
1. How big is the global Self-administered Parenteral market?
2. What is the demand of the global Self-administered Parenteral market?
3. What is the year over year growth of the global Self-administered Parenteral market?
4. What is the production and production value of the global Self-administered Parenteral market?
5. Who are the key producers in the global Self-administered Parenteral market?
This report studies the global Self-administered Parenteral production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Self-administered Parenteral, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Self-administered Parenteral that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Self-administered Parenteral total production and demand, 2019-2030, (K Units)
Global Self-administered Parenteral total production value, 2019-2030, (USD Million)
Global Self-administered Parenteral production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-administered Parenteral consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Self-administered Parenteral domestic production, consumption, key domestic manufacturers and share
Global Self-administered Parenteral production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Self-administered Parenteral production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Self-administered Parenteral production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Self-administered Parenteral market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Becton, Dickinson and Company, scPharmaceuticals, Harro Hofliger, Owen Mumford, Haselmeier, Stevanato Group, Ypsomed AG, Solteam Group and AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Self-administered Parenteral market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Self-administered Parenteral Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Pre-filled Syringes
- Autoinjectors
- Pen Injectors
- Others
- Pharmacy
- Online Sales
- Other
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Hofliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable lnjections
- CCBio
- Phillips-Medisize Corporation
- Sorrel Medical
- Krontec Healthcare
- Subcuject Aps
- Ascendia Pharmaceuticals
- West Pharmaceutical Services, Inc.
1. How big is the global Self-administered Parenteral market?
2. What is the demand of the global Self-administered Parenteral market?
3. What is the year over year growth of the global Self-administered Parenteral market?
4. What is the production and production value of the global Self-administered Parenteral market?
5. Who are the key producers in the global Self-administered Parenteral market?
1 SUPPLY SUMMARY
1.1 Self-administered Parenteral Introduction
1.2 World Self-administered Parenteral Supply & Forecast
1.2.1 World Self-administered Parenteral Production Value (2019 & 2023 & 2030)
1.2.2 World Self-administered Parenteral Production (2019-2030)
1.2.3 World Self-administered Parenteral Pricing Trends (2019-2030)
1.3 World Self-administered Parenteral Production by Region (Based on Production Site)
1.3.1 World Self-administered Parenteral Production Value by Region (2019-2030)
1.3.2 World Self-administered Parenteral Production by Region (2019-2030)
1.3.3 World Self-administered Parenteral Average Price by Region (2019-2030)
1.3.4 North America Self-administered Parenteral Production (2019-2030)
1.3.5 Europe Self-administered Parenteral Production (2019-2030)
1.3.6 China Self-administered Parenteral Production (2019-2030)
1.3.7 Japan Self-administered Parenteral Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Self-administered Parenteral Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Self-administered Parenteral Major Market Trends
2 DEMAND SUMMARY
2.1 World Self-administered Parenteral Demand (2019-2030)
2.2 World Self-administered Parenteral Consumption by Region
2.2.1 World Self-administered Parenteral Consumption by Region (2019-2024)
2.2.2 World Self-administered Parenteral Consumption Forecast by Region (2025-2030)
2.3 United States Self-administered Parenteral Consumption (2019-2030)
2.4 China Self-administered Parenteral Consumption (2019-2030)
2.5 Europe Self-administered Parenteral Consumption (2019-2030)
2.6 Japan Self-administered Parenteral Consumption (2019-2030)
2.7 South Korea Self-administered Parenteral Consumption (2019-2030)
2.8 ASEAN Self-administered Parenteral Consumption (2019-2030)
2.9 India Self-administered Parenteral Consumption (2019-2030)
3 WORLD SELF-ADMINISTERED PARENTERAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Self-administered Parenteral Production Value by Manufacturer (2019-2024)
3.2 World Self-administered Parenteral Production by Manufacturer (2019-2024)
3.3 World Self-administered Parenteral Average Price by Manufacturer (2019-2024)
3.4 Self-administered Parenteral Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Self-administered Parenteral Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Self-administered Parenteral in 2023
3.5.3 Global Concentration Ratios (CR8) for Self-administered Parenteral in 2023
3.6 Self-administered Parenteral Market: Overall Company Footprint Analysis
3.6.1 Self-administered Parenteral Market: Region Footprint
3.6.2 Self-administered Parenteral Market: Company Product Type Footprint
3.6.3 Self-administered Parenteral Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Self-administered Parenteral Production Value Comparison
4.1.1 United States VS China: Self-administered Parenteral Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Self-administered Parenteral Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Self-administered Parenteral Production Comparison
4.2.1 United States VS China: Self-administered Parenteral Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Self-administered Parenteral Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Self-administered Parenteral Consumption Comparison
4.3.1 United States VS China: Self-administered Parenteral Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Self-administered Parenteral Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Self-administered Parenteral Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Self-administered Parenteral Production Value (2019-2024)
4.4.3 United States Based Manufacturers Self-administered Parenteral Production (2019-2024)
4.5 China Based Self-administered Parenteral Manufacturers and Market Share
4.5.1 China Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Self-administered Parenteral Production Value (2019-2024)
4.5.3 China Based Manufacturers Self-administered Parenteral Production (2019-2024)
4.6 Rest of World Based Self-administered Parenteral Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Self-administered Parenteral Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Self-administered Parenteral Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Self-administered Parenteral Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Pre-filled Syringes
5.2.2 Autoinjectors
5.2.3 Pen Injectors
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Self-administered Parenteral Production by Type (2019-2030)
5.3.2 World Self-administered Parenteral Production Value by Type (2019-2030)
5.3.3 World Self-administered Parenteral Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Self-administered Parenteral Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmacy
6.2.2 Online Sales
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Self-administered Parenteral Production by Application (2019-2030)
6.3.2 World Self-administered Parenteral Production Value by Application (2019-2030)
6.3.3 World Self-administered Parenteral Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Details
7.1.2 Becton, Dickinson and Company Major Business
7.1.3 Becton, Dickinson and Company Self-administered Parenteral Product and Services
7.1.4 Becton, Dickinson and Company Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Becton, Dickinson and Company Recent Developments/Updates
7.1.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
7.2 scPharmaceuticals
7.2.1 scPharmaceuticals Details
7.2.2 scPharmaceuticals Major Business
7.2.3 scPharmaceuticals Self-administered Parenteral Product and Services
7.2.4 scPharmaceuticals Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 scPharmaceuticals Recent Developments/Updates
7.2.6 scPharmaceuticals Competitive Strengths & Weaknesses
7.3 Harro Hofliger
7.3.1 Harro Hofliger Details
7.3.2 Harro Hofliger Major Business
7.3.3 Harro Hofliger Self-administered Parenteral Product and Services
7.3.4 Harro Hofliger Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Harro Hofliger Recent Developments/Updates
7.3.6 Harro Hofliger Competitive Strengths & Weaknesses
7.4 Owen Mumford
7.4.1 Owen Mumford Details
7.4.2 Owen Mumford Major Business
7.4.3 Owen Mumford Self-administered Parenteral Product and Services
7.4.4 Owen Mumford Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Owen Mumford Recent Developments/Updates
7.4.6 Owen Mumford Competitive Strengths & Weaknesses
7.5 Haselmeier
7.5.1 Haselmeier Details
7.5.2 Haselmeier Major Business
7.5.3 Haselmeier Self-administered Parenteral Product and Services
7.5.4 Haselmeier Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Haselmeier Recent Developments/Updates
7.5.6 Haselmeier Competitive Strengths & Weaknesses
7.6 Stevanato Group
7.6.1 Stevanato Group Details
7.6.2 Stevanato Group Major Business
7.6.3 Stevanato Group Self-administered Parenteral Product and Services
7.6.4 Stevanato Group Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Stevanato Group Recent Developments/Updates
7.6.6 Stevanato Group Competitive Strengths & Weaknesses
7.7 Ypsomed AG
7.7.1 Ypsomed AG Details
7.7.2 Ypsomed AG Major Business
7.7.3 Ypsomed AG Self-administered Parenteral Product and Services
7.7.4 Ypsomed AG Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Ypsomed AG Recent Developments/Updates
7.7.6 Ypsomed AG Competitive Strengths & Weaknesses
7.8 Solteam Group
7.8.1 Solteam Group Details
7.8.2 Solteam Group Major Business
7.8.3 Solteam Group Self-administered Parenteral Product and Services
7.8.4 Solteam Group Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Solteam Group Recent Developments/Updates
7.8.6 Solteam Group Competitive Strengths & Weaknesses
7.9 AstraZeneca
7.9.1 AstraZeneca Details
7.9.2 AstraZeneca Major Business
7.9.3 AstraZeneca Self-administered Parenteral Product and Services
7.9.4 AstraZeneca Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 AstraZeneca Recent Developments/Updates
7.9.6 AstraZeneca Competitive Strengths & Weaknesses
7.10 Enable lnjections
7.10.1 Enable lnjections Details
7.10.2 Enable lnjections Major Business
7.10.3 Enable lnjections Self-administered Parenteral Product and Services
7.10.4 Enable lnjections Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Enable lnjections Recent Developments/Updates
7.10.6 Enable lnjections Competitive Strengths & Weaknesses
7.11 CCBio
7.11.1 CCBio Details
7.11.2 CCBio Major Business
7.11.3 CCBio Self-administered Parenteral Product and Services
7.11.4 CCBio Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 CCBio Recent Developments/Updates
7.11.6 CCBio Competitive Strengths & Weaknesses
7.12 Phillips-Medisize Corporation
7.12.1 Phillips-Medisize Corporation Details
7.12.2 Phillips-Medisize Corporation Major Business
7.12.3 Phillips-Medisize Corporation Self-administered Parenteral Product and Services
7.12.4 Phillips-Medisize Corporation Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Phillips-Medisize Corporation Recent Developments/Updates
7.12.6 Phillips-Medisize Corporation Competitive Strengths & Weaknesses
7.13 Sorrel Medical
7.13.1 Sorrel Medical Details
7.13.2 Sorrel Medical Major Business
7.13.3 Sorrel Medical Self-administered Parenteral Product and Services
7.13.4 Sorrel Medical Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Sorrel Medical Recent Developments/Updates
7.13.6 Sorrel Medical Competitive Strengths & Weaknesses
7.14 Krontec Healthcare
7.14.1 Krontec Healthcare Details
7.14.2 Krontec Healthcare Major Business
7.14.3 Krontec Healthcare Self-administered Parenteral Product and Services
7.14.4 Krontec Healthcare Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Krontec Healthcare Recent Developments/Updates
7.14.6 Krontec Healthcare Competitive Strengths & Weaknesses
7.15 Subcuject Aps
7.15.1 Subcuject Aps Details
7.15.2 Subcuject Aps Major Business
7.15.3 Subcuject Aps Self-administered Parenteral Product and Services
7.15.4 Subcuject Aps Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Subcuject Aps Recent Developments/Updates
7.15.6 Subcuject Aps Competitive Strengths & Weaknesses
7.16 Ascendia Pharmaceuticals
7.16.1 Ascendia Pharmaceuticals Details
7.16.2 Ascendia Pharmaceuticals Major Business
7.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
7.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
7.16.6 Ascendia Pharmaceuticals Competitive Strengths & Weaknesses
7.17 West Pharmaceutical Services, Inc.
7.17.1 West Pharmaceutical Services, Inc. Details
7.17.2 West Pharmaceutical Services, Inc. Major Business
7.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
7.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
7.17.6 West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Self-administered Parenteral Industry Chain
8.2 Self-administered Parenteral Upstream Analysis
8.2.1 Self-administered Parenteral Core Raw Materials
8.2.2 Main Manufacturers of Self-administered Parenteral Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Self-administered Parenteral Production Mode
8.6 Self-administered Parenteral Procurement Model
8.7 Self-administered Parenteral Industry Sales Model and Sales Channels
8.7.1 Self-administered Parenteral Sales Model
8.7.2 Self-administered Parenteral Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Self-administered Parenteral Introduction
1.2 World Self-administered Parenteral Supply & Forecast
1.2.1 World Self-administered Parenteral Production Value (2019 & 2023 & 2030)
1.2.2 World Self-administered Parenteral Production (2019-2030)
1.2.3 World Self-administered Parenteral Pricing Trends (2019-2030)
1.3 World Self-administered Parenteral Production by Region (Based on Production Site)
1.3.1 World Self-administered Parenteral Production Value by Region (2019-2030)
1.3.2 World Self-administered Parenteral Production by Region (2019-2030)
1.3.3 World Self-administered Parenteral Average Price by Region (2019-2030)
1.3.4 North America Self-administered Parenteral Production (2019-2030)
1.3.5 Europe Self-administered Parenteral Production (2019-2030)
1.3.6 China Self-administered Parenteral Production (2019-2030)
1.3.7 Japan Self-administered Parenteral Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Self-administered Parenteral Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Self-administered Parenteral Major Market Trends
2 DEMAND SUMMARY
2.1 World Self-administered Parenteral Demand (2019-2030)
2.2 World Self-administered Parenteral Consumption by Region
2.2.1 World Self-administered Parenteral Consumption by Region (2019-2024)
2.2.2 World Self-administered Parenteral Consumption Forecast by Region (2025-2030)
2.3 United States Self-administered Parenteral Consumption (2019-2030)
2.4 China Self-administered Parenteral Consumption (2019-2030)
2.5 Europe Self-administered Parenteral Consumption (2019-2030)
2.6 Japan Self-administered Parenteral Consumption (2019-2030)
2.7 South Korea Self-administered Parenteral Consumption (2019-2030)
2.8 ASEAN Self-administered Parenteral Consumption (2019-2030)
2.9 India Self-administered Parenteral Consumption (2019-2030)
3 WORLD SELF-ADMINISTERED PARENTERAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Self-administered Parenteral Production Value by Manufacturer (2019-2024)
3.2 World Self-administered Parenteral Production by Manufacturer (2019-2024)
3.3 World Self-administered Parenteral Average Price by Manufacturer (2019-2024)
3.4 Self-administered Parenteral Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Self-administered Parenteral Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Self-administered Parenteral in 2023
3.5.3 Global Concentration Ratios (CR8) for Self-administered Parenteral in 2023
3.6 Self-administered Parenteral Market: Overall Company Footprint Analysis
3.6.1 Self-administered Parenteral Market: Region Footprint
3.6.2 Self-administered Parenteral Market: Company Product Type Footprint
3.6.3 Self-administered Parenteral Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Self-administered Parenteral Production Value Comparison
4.1.1 United States VS China: Self-administered Parenteral Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Self-administered Parenteral Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Self-administered Parenteral Production Comparison
4.2.1 United States VS China: Self-administered Parenteral Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Self-administered Parenteral Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Self-administered Parenteral Consumption Comparison
4.3.1 United States VS China: Self-administered Parenteral Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Self-administered Parenteral Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Self-administered Parenteral Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Self-administered Parenteral Production Value (2019-2024)
4.4.3 United States Based Manufacturers Self-administered Parenteral Production (2019-2024)
4.5 China Based Self-administered Parenteral Manufacturers and Market Share
4.5.1 China Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Self-administered Parenteral Production Value (2019-2024)
4.5.3 China Based Manufacturers Self-administered Parenteral Production (2019-2024)
4.6 Rest of World Based Self-administered Parenteral Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Self-administered Parenteral Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Self-administered Parenteral Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Self-administered Parenteral Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Pre-filled Syringes
5.2.2 Autoinjectors
5.2.3 Pen Injectors
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Self-administered Parenteral Production by Type (2019-2030)
5.3.2 World Self-administered Parenteral Production Value by Type (2019-2030)
5.3.3 World Self-administered Parenteral Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Self-administered Parenteral Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmacy
6.2.2 Online Sales
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Self-administered Parenteral Production by Application (2019-2030)
6.3.2 World Self-administered Parenteral Production Value by Application (2019-2030)
6.3.3 World Self-administered Parenteral Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Details
7.1.2 Becton, Dickinson and Company Major Business
7.1.3 Becton, Dickinson and Company Self-administered Parenteral Product and Services
7.1.4 Becton, Dickinson and Company Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Becton, Dickinson and Company Recent Developments/Updates
7.1.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
7.2 scPharmaceuticals
7.2.1 scPharmaceuticals Details
7.2.2 scPharmaceuticals Major Business
7.2.3 scPharmaceuticals Self-administered Parenteral Product and Services
7.2.4 scPharmaceuticals Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 scPharmaceuticals Recent Developments/Updates
7.2.6 scPharmaceuticals Competitive Strengths & Weaknesses
7.3 Harro Hofliger
7.3.1 Harro Hofliger Details
7.3.2 Harro Hofliger Major Business
7.3.3 Harro Hofliger Self-administered Parenteral Product and Services
7.3.4 Harro Hofliger Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Harro Hofliger Recent Developments/Updates
7.3.6 Harro Hofliger Competitive Strengths & Weaknesses
7.4 Owen Mumford
7.4.1 Owen Mumford Details
7.4.2 Owen Mumford Major Business
7.4.3 Owen Mumford Self-administered Parenteral Product and Services
7.4.4 Owen Mumford Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Owen Mumford Recent Developments/Updates
7.4.6 Owen Mumford Competitive Strengths & Weaknesses
7.5 Haselmeier
7.5.1 Haselmeier Details
7.5.2 Haselmeier Major Business
7.5.3 Haselmeier Self-administered Parenteral Product and Services
7.5.4 Haselmeier Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Haselmeier Recent Developments/Updates
7.5.6 Haselmeier Competitive Strengths & Weaknesses
7.6 Stevanato Group
7.6.1 Stevanato Group Details
7.6.2 Stevanato Group Major Business
7.6.3 Stevanato Group Self-administered Parenteral Product and Services
7.6.4 Stevanato Group Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Stevanato Group Recent Developments/Updates
7.6.6 Stevanato Group Competitive Strengths & Weaknesses
7.7 Ypsomed AG
7.7.1 Ypsomed AG Details
7.7.2 Ypsomed AG Major Business
7.7.3 Ypsomed AG Self-administered Parenteral Product and Services
7.7.4 Ypsomed AG Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Ypsomed AG Recent Developments/Updates
7.7.6 Ypsomed AG Competitive Strengths & Weaknesses
7.8 Solteam Group
7.8.1 Solteam Group Details
7.8.2 Solteam Group Major Business
7.8.3 Solteam Group Self-administered Parenteral Product and Services
7.8.4 Solteam Group Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Solteam Group Recent Developments/Updates
7.8.6 Solteam Group Competitive Strengths & Weaknesses
7.9 AstraZeneca
7.9.1 AstraZeneca Details
7.9.2 AstraZeneca Major Business
7.9.3 AstraZeneca Self-administered Parenteral Product and Services
7.9.4 AstraZeneca Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 AstraZeneca Recent Developments/Updates
7.9.6 AstraZeneca Competitive Strengths & Weaknesses
7.10 Enable lnjections
7.10.1 Enable lnjections Details
7.10.2 Enable lnjections Major Business
7.10.3 Enable lnjections Self-administered Parenteral Product and Services
7.10.4 Enable lnjections Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Enable lnjections Recent Developments/Updates
7.10.6 Enable lnjections Competitive Strengths & Weaknesses
7.11 CCBio
7.11.1 CCBio Details
7.11.2 CCBio Major Business
7.11.3 CCBio Self-administered Parenteral Product and Services
7.11.4 CCBio Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 CCBio Recent Developments/Updates
7.11.6 CCBio Competitive Strengths & Weaknesses
7.12 Phillips-Medisize Corporation
7.12.1 Phillips-Medisize Corporation Details
7.12.2 Phillips-Medisize Corporation Major Business
7.12.3 Phillips-Medisize Corporation Self-administered Parenteral Product and Services
7.12.4 Phillips-Medisize Corporation Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Phillips-Medisize Corporation Recent Developments/Updates
7.12.6 Phillips-Medisize Corporation Competitive Strengths & Weaknesses
7.13 Sorrel Medical
7.13.1 Sorrel Medical Details
7.13.2 Sorrel Medical Major Business
7.13.3 Sorrel Medical Self-administered Parenteral Product and Services
7.13.4 Sorrel Medical Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Sorrel Medical Recent Developments/Updates
7.13.6 Sorrel Medical Competitive Strengths & Weaknesses
7.14 Krontec Healthcare
7.14.1 Krontec Healthcare Details
7.14.2 Krontec Healthcare Major Business
7.14.3 Krontec Healthcare Self-administered Parenteral Product and Services
7.14.4 Krontec Healthcare Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Krontec Healthcare Recent Developments/Updates
7.14.6 Krontec Healthcare Competitive Strengths & Weaknesses
7.15 Subcuject Aps
7.15.1 Subcuject Aps Details
7.15.2 Subcuject Aps Major Business
7.15.3 Subcuject Aps Self-administered Parenteral Product and Services
7.15.4 Subcuject Aps Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Subcuject Aps Recent Developments/Updates
7.15.6 Subcuject Aps Competitive Strengths & Weaknesses
7.16 Ascendia Pharmaceuticals
7.16.1 Ascendia Pharmaceuticals Details
7.16.2 Ascendia Pharmaceuticals Major Business
7.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
7.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
7.16.6 Ascendia Pharmaceuticals Competitive Strengths & Weaknesses
7.17 West Pharmaceutical Services, Inc.
7.17.1 West Pharmaceutical Services, Inc. Details
7.17.2 West Pharmaceutical Services, Inc. Major Business
7.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
7.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
7.17.6 West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Self-administered Parenteral Industry Chain
8.2 Self-administered Parenteral Upstream Analysis
8.2.1 Self-administered Parenteral Core Raw Materials
8.2.2 Main Manufacturers of Self-administered Parenteral Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Self-administered Parenteral Production Mode
8.6 Self-administered Parenteral Procurement Model
8.7 Self-administered Parenteral Industry Sales Model and Sales Channels
8.7.1 Self-administered Parenteral Sales Model
8.7.2 Self-administered Parenteral Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Self-administered Parenteral Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Self-administered Parenteral Production Value by Region (2019-2024) & (USD Million)
Table 3. World Self-administered Parenteral Production Value by Region (2025-2030) & (USD Million)
Table 4. World Self-administered Parenteral Production Value Market Share by Region (2019-2024)
Table 5. World Self-administered Parenteral Production Value Market Share by Region (2025-2030)
Table 6. World Self-administered Parenteral Production by Region (2019-2024) & (K Units)
Table 7. World Self-administered Parenteral Production by Region (2025-2030) & (K Units)
Table 8. World Self-administered Parenteral Production Market Share by Region (2019-2024)
Table 9. World Self-administered Parenteral Production Market Share by Region (2025-2030)
Table 10. World Self-administered Parenteral Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Self-administered Parenteral Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Self-administered Parenteral Major Market Trends
Table 13. World Self-administered Parenteral Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Self-administered Parenteral Consumption by Region (2019-2024) & (K Units)
Table 15. World Self-administered Parenteral Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Self-administered Parenteral Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Self-administered Parenteral Producers in 2023
Table 18. World Self-administered Parenteral Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Self-administered Parenteral Producers in 2023
Table 20. World Self-administered Parenteral Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Self-administered Parenteral Company Evaluation Quadrant
Table 22. World Self-administered Parenteral Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Self-administered Parenteral Production Site of Key Manufacturer
Table 24. Self-administered Parenteral Market: Company Product Type Footprint
Table 25. Self-administered Parenteral Market: Company Product Application Footprint
Table 26. Self-administered Parenteral Competitive Factors
Table 27. Self-administered Parenteral New Entrant and Capacity Expansion Plans
Table 28. Self-administered Parenteral Mergers & Acquisitions Activity
Table 29. United States VS China Self-administered Parenteral Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Self-administered Parenteral Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Self-administered Parenteral Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Self-administered Parenteral Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Self-administered Parenteral Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Self-administered Parenteral Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Self-administered Parenteral Production Market Share (2019-2024)
Table 37. China Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Self-administered Parenteral Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Self-administered Parenteral Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Self-administered Parenteral Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Self-administered Parenteral Production Market Share (2019-2024)
Table 42. Rest of World Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Self-administered Parenteral Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Self-administered Parenteral Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Self-administered Parenteral Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Self-administered Parenteral Production Market Share (2019-2024)
Table 47. World Self-administered Parenteral Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Self-administered Parenteral Production by Type (2019-2024) & (K Units)
Table 49. World Self-administered Parenteral Production by Type (2025-2030) & (K Units)
Table 50. World Self-administered Parenteral Production Value by Type (2019-2024) & (USD Million)
Table 51. World Self-administered Parenteral Production Value by Type (2025-2030) & (USD Million)
Table 52. World Self-administered Parenteral Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Self-administered Parenteral Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Self-administered Parenteral Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Self-administered Parenteral Production by Application (2019-2024) & (K Units)
Table 56. World Self-administered Parenteral Production by Application (2025-2030) & (K Units)
Table 57. World Self-administered Parenteral Production Value by Application (2019-2024) & (USD Million)
Table 58. World Self-administered Parenteral Production Value by Application (2025-2030) & (USD Million)
Table 59. World Self-administered Parenteral Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Self-administered Parenteral Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 62. Becton, Dickinson and Company Major Business
Table 63. Becton, Dickinson and Company Self-administered Parenteral Product and Services
Table 64. Becton, Dickinson and Company Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Becton, Dickinson and Company Recent Developments/Updates
Table 66. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 67. scPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. scPharmaceuticals Major Business
Table 69. scPharmaceuticals Self-administered Parenteral Product and Services
Table 70. scPharmaceuticals Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. scPharmaceuticals Recent Developments/Updates
Table 72. scPharmaceuticals Competitive Strengths & Weaknesses
Table 73. Harro Hofliger Basic Information, Manufacturing Base and Competitors
Table 74. Harro Hofliger Major Business
Table 75. Harro Hofliger Self-administered Parenteral Product and Services
Table 76. Harro Hofliger Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Harro Hofliger Recent Developments/Updates
Table 78. Harro Hofliger Competitive Strengths & Weaknesses
Table 79. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 80. Owen Mumford Major Business
Table 81. Owen Mumford Self-administered Parenteral Product and Services
Table 82. Owen Mumford Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Owen Mumford Recent Developments/Updates
Table 84. Owen Mumford Competitive Strengths & Weaknesses
Table 85. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 86. Haselmeier Major Business
Table 87. Haselmeier Self-administered Parenteral Product and Services
Table 88. Haselmeier Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Haselmeier Recent Developments/Updates
Table 90. Haselmeier Competitive Strengths & Weaknesses
Table 91. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 92. Stevanato Group Major Business
Table 93. Stevanato Group Self-administered Parenteral Product and Services
Table 94. Stevanato Group Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Stevanato Group Recent Developments/Updates
Table 96. Stevanato Group Competitive Strengths & Weaknesses
Table 97. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 98. Ypsomed AG Major Business
Table 99. Ypsomed AG Self-administered Parenteral Product and Services
Table 100. Ypsomed AG Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Ypsomed AG Recent Developments/Updates
Table 102. Ypsomed AG Competitive Strengths & Weaknesses
Table 103. Solteam Group Basic Information, Manufacturing Base and Competitors
Table 104. Solteam Group Major Business
Table 105. Solteam Group Self-administered Parenteral Product and Services
Table 106. Solteam Group Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Solteam Group Recent Developments/Updates
Table 108. Solteam Group Competitive Strengths & Weaknesses
Table 109. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 110. AstraZeneca Major Business
Table 111. AstraZeneca Self-administered Parenteral Product and Services
Table 112. AstraZeneca Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. AstraZeneca Recent Developments/Updates
Table 114. AstraZeneca Competitive Strengths & Weaknesses
Table 115. Enable lnjections Basic Information, Manufacturing Base and Competitors
Table 116. Enable lnjections Major Business
Table 117. Enable lnjections Self-administered Parenteral Product and Services
Table 118. Enable lnjections Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Enable lnjections Recent Developments/Updates
Table 120. Enable lnjections Competitive Strengths & Weaknesses
Table 121. CCBio Basic Information, Manufacturing Base and Competitors
Table 122. CCBio Major Business
Table 123. CCBio Self-administered Parenteral Product and Services
Table 124. CCBio Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. CCBio Recent Developments/Updates
Table 126. CCBio Competitive Strengths & Weaknesses
Table 127. Phillips-Medisize Corporation Basic Information, Manufacturing Base and Competitors
Table 128. Phillips-Medisize Corporation Major Business
Table 129. Phillips-Medisize Corporation Self-administered Parenteral Product and Services
Table 130. Phillips-Medisize Corporation Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Phillips-Medisize Corporation Recent Developments/Updates
Table 132. Phillips-Medisize Corporation Competitive Strengths & Weaknesses
Table 133. Sorrel Medical Basic Information, Manufacturing Base and Competitors
Table 134. Sorrel Medical Major Business
Table 135. Sorrel Medical Self-administered Parenteral Product and Services
Table 136. Sorrel Medical Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Sorrel Medical Recent Developments/Updates
Table 138. Sorrel Medical Competitive Strengths & Weaknesses
Table 139. Krontec Healthcare Basic Information, Manufacturing Base and Competitors
Table 140. Krontec Healthcare Major Business
Table 141. Krontec Healthcare Self-administered Parenteral Product and Services
Table 142. Krontec Healthcare Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Krontec Healthcare Recent Developments/Updates
Table 144. Krontec Healthcare Competitive Strengths & Weaknesses
Table 145. Subcuject Aps Basic Information, Manufacturing Base and Competitors
Table 146. Subcuject Aps Major Business
Table 147. Subcuject Aps Self-administered Parenteral Product and Services
Table 148. Subcuject Aps Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Subcuject Aps Recent Developments/Updates
Table 150. Subcuject Aps Competitive Strengths & Weaknesses
Table 151. Ascendia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. Ascendia Pharmaceuticals Major Business
Table 153. Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
Table 154. Ascendia Pharmaceuticals Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Ascendia Pharmaceuticals Recent Developments/Updates
Table 156. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 157. West Pharmaceutical Services, Inc. Major Business
Table 158. West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
Table 159. West Pharmaceutical Services, Inc. Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 160. Global Key Players of Self-administered Parenteral Upstream (Raw Materials)
Table 161. Self-administered Parenteral Typical Customers
Table 162. Self-administered Parenteral Typical Distributors
LIST OF FIGURE
Figure 1. Self-administered Parenteral Picture
Figure 2. World Self-administered Parenteral Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Self-administered Parenteral Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 5. World Self-administered Parenteral Average Price (2019-2030) & (US$/Unit)
Figure 6. World Self-administered Parenteral Production Value Market Share by Region (2019-2030)
Figure 7. World Self-administered Parenteral Production Market Share by Region (2019-2030)
Figure 8. North America Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 9. Europe Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 10. China Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 11. Japan Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 12. Self-administered Parenteral Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 15. World Self-administered Parenteral Consumption Market Share by Region (2019-2030)
Figure 16. United States Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 17. China Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 18. Europe Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 19. Japan Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 20. South Korea Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 22. India Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Self-administered Parenteral by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Self-administered Parenteral Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Self-administered Parenteral Markets in 2023
Figure 26. United States VS China: Self-administered Parenteral Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Self-administered Parenteral Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Self-administered Parenteral Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Self-administered Parenteral Production Market Share 2023
Figure 30. China Based Manufacturers Self-administered Parenteral Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Self-administered Parenteral Production Market Share 2023
Figure 32. World Self-administered Parenteral Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Self-administered Parenteral Production Value Market Share by Type in 2023
Figure 34. Pre-filled Syringes
Figure 35. Autoinjectors
Figure 36. Pen Injectors
Figure 37. Others
Figure 38. World Self-administered Parenteral Production Market Share by Type (2019-2030)
Figure 39. World Self-administered Parenteral Production Value Market Share by Type (2019-2030)
Figure 40. World Self-administered Parenteral Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Self-administered Parenteral Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Self-administered Parenteral Production Value Market Share by Application in 2023
Figure 43. Pharmacy
Figure 44. Online Sales
Figure 45. Other
Figure 46. World Self-administered Parenteral Production Market Share by Application (2019-2030)
Figure 47. World Self-administered Parenteral Production Value Market Share by Application (2019-2030)
Figure 48. World Self-administered Parenteral Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Self-administered Parenteral Industry Chain
Figure 50. Self-administered Parenteral Procurement Model
Figure 51. Self-administered Parenteral Sales Model
Figure 52. Self-administered Parenteral Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Table 1. World Self-administered Parenteral Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Self-administered Parenteral Production Value by Region (2019-2024) & (USD Million)
Table 3. World Self-administered Parenteral Production Value by Region (2025-2030) & (USD Million)
Table 4. World Self-administered Parenteral Production Value Market Share by Region (2019-2024)
Table 5. World Self-administered Parenteral Production Value Market Share by Region (2025-2030)
Table 6. World Self-administered Parenteral Production by Region (2019-2024) & (K Units)
Table 7. World Self-administered Parenteral Production by Region (2025-2030) & (K Units)
Table 8. World Self-administered Parenteral Production Market Share by Region (2019-2024)
Table 9. World Self-administered Parenteral Production Market Share by Region (2025-2030)
Table 10. World Self-administered Parenteral Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Self-administered Parenteral Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Self-administered Parenteral Major Market Trends
Table 13. World Self-administered Parenteral Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Self-administered Parenteral Consumption by Region (2019-2024) & (K Units)
Table 15. World Self-administered Parenteral Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Self-administered Parenteral Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Self-administered Parenteral Producers in 2023
Table 18. World Self-administered Parenteral Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Self-administered Parenteral Producers in 2023
Table 20. World Self-administered Parenteral Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Self-administered Parenteral Company Evaluation Quadrant
Table 22. World Self-administered Parenteral Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Self-administered Parenteral Production Site of Key Manufacturer
Table 24. Self-administered Parenteral Market: Company Product Type Footprint
Table 25. Self-administered Parenteral Market: Company Product Application Footprint
Table 26. Self-administered Parenteral Competitive Factors
Table 27. Self-administered Parenteral New Entrant and Capacity Expansion Plans
Table 28. Self-administered Parenteral Mergers & Acquisitions Activity
Table 29. United States VS China Self-administered Parenteral Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Self-administered Parenteral Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Self-administered Parenteral Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Self-administered Parenteral Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Self-administered Parenteral Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Self-administered Parenteral Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Self-administered Parenteral Production Market Share (2019-2024)
Table 37. China Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Self-administered Parenteral Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Self-administered Parenteral Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Self-administered Parenteral Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Self-administered Parenteral Production Market Share (2019-2024)
Table 42. Rest of World Based Self-administered Parenteral Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Self-administered Parenteral Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Self-administered Parenteral Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Self-administered Parenteral Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Self-administered Parenteral Production Market Share (2019-2024)
Table 47. World Self-administered Parenteral Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Self-administered Parenteral Production by Type (2019-2024) & (K Units)
Table 49. World Self-administered Parenteral Production by Type (2025-2030) & (K Units)
Table 50. World Self-administered Parenteral Production Value by Type (2019-2024) & (USD Million)
Table 51. World Self-administered Parenteral Production Value by Type (2025-2030) & (USD Million)
Table 52. World Self-administered Parenteral Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Self-administered Parenteral Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Self-administered Parenteral Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Self-administered Parenteral Production by Application (2019-2024) & (K Units)
Table 56. World Self-administered Parenteral Production by Application (2025-2030) & (K Units)
Table 57. World Self-administered Parenteral Production Value by Application (2019-2024) & (USD Million)
Table 58. World Self-administered Parenteral Production Value by Application (2025-2030) & (USD Million)
Table 59. World Self-administered Parenteral Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Self-administered Parenteral Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 62. Becton, Dickinson and Company Major Business
Table 63. Becton, Dickinson and Company Self-administered Parenteral Product and Services
Table 64. Becton, Dickinson and Company Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Becton, Dickinson and Company Recent Developments/Updates
Table 66. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 67. scPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. scPharmaceuticals Major Business
Table 69. scPharmaceuticals Self-administered Parenteral Product and Services
Table 70. scPharmaceuticals Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. scPharmaceuticals Recent Developments/Updates
Table 72. scPharmaceuticals Competitive Strengths & Weaknesses
Table 73. Harro Hofliger Basic Information, Manufacturing Base and Competitors
Table 74. Harro Hofliger Major Business
Table 75. Harro Hofliger Self-administered Parenteral Product and Services
Table 76. Harro Hofliger Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Harro Hofliger Recent Developments/Updates
Table 78. Harro Hofliger Competitive Strengths & Weaknesses
Table 79. Owen Mumford Basic Information, Manufacturing Base and Competitors
Table 80. Owen Mumford Major Business
Table 81. Owen Mumford Self-administered Parenteral Product and Services
Table 82. Owen Mumford Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Owen Mumford Recent Developments/Updates
Table 84. Owen Mumford Competitive Strengths & Weaknesses
Table 85. Haselmeier Basic Information, Manufacturing Base and Competitors
Table 86. Haselmeier Major Business
Table 87. Haselmeier Self-administered Parenteral Product and Services
Table 88. Haselmeier Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Haselmeier Recent Developments/Updates
Table 90. Haselmeier Competitive Strengths & Weaknesses
Table 91. Stevanato Group Basic Information, Manufacturing Base and Competitors
Table 92. Stevanato Group Major Business
Table 93. Stevanato Group Self-administered Parenteral Product and Services
Table 94. Stevanato Group Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Stevanato Group Recent Developments/Updates
Table 96. Stevanato Group Competitive Strengths & Weaknesses
Table 97. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 98. Ypsomed AG Major Business
Table 99. Ypsomed AG Self-administered Parenteral Product and Services
Table 100. Ypsomed AG Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Ypsomed AG Recent Developments/Updates
Table 102. Ypsomed AG Competitive Strengths & Weaknesses
Table 103. Solteam Group Basic Information, Manufacturing Base and Competitors
Table 104. Solteam Group Major Business
Table 105. Solteam Group Self-administered Parenteral Product and Services
Table 106. Solteam Group Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Solteam Group Recent Developments/Updates
Table 108. Solteam Group Competitive Strengths & Weaknesses
Table 109. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 110. AstraZeneca Major Business
Table 111. AstraZeneca Self-administered Parenteral Product and Services
Table 112. AstraZeneca Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. AstraZeneca Recent Developments/Updates
Table 114. AstraZeneca Competitive Strengths & Weaknesses
Table 115. Enable lnjections Basic Information, Manufacturing Base and Competitors
Table 116. Enable lnjections Major Business
Table 117. Enable lnjections Self-administered Parenteral Product and Services
Table 118. Enable lnjections Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Enable lnjections Recent Developments/Updates
Table 120. Enable lnjections Competitive Strengths & Weaknesses
Table 121. CCBio Basic Information, Manufacturing Base and Competitors
Table 122. CCBio Major Business
Table 123. CCBio Self-administered Parenteral Product and Services
Table 124. CCBio Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. CCBio Recent Developments/Updates
Table 126. CCBio Competitive Strengths & Weaknesses
Table 127. Phillips-Medisize Corporation Basic Information, Manufacturing Base and Competitors
Table 128. Phillips-Medisize Corporation Major Business
Table 129. Phillips-Medisize Corporation Self-administered Parenteral Product and Services
Table 130. Phillips-Medisize Corporation Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Phillips-Medisize Corporation Recent Developments/Updates
Table 132. Phillips-Medisize Corporation Competitive Strengths & Weaknesses
Table 133. Sorrel Medical Basic Information, Manufacturing Base and Competitors
Table 134. Sorrel Medical Major Business
Table 135. Sorrel Medical Self-administered Parenteral Product and Services
Table 136. Sorrel Medical Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Sorrel Medical Recent Developments/Updates
Table 138. Sorrel Medical Competitive Strengths & Weaknesses
Table 139. Krontec Healthcare Basic Information, Manufacturing Base and Competitors
Table 140. Krontec Healthcare Major Business
Table 141. Krontec Healthcare Self-administered Parenteral Product and Services
Table 142. Krontec Healthcare Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Krontec Healthcare Recent Developments/Updates
Table 144. Krontec Healthcare Competitive Strengths & Weaknesses
Table 145. Subcuject Aps Basic Information, Manufacturing Base and Competitors
Table 146. Subcuject Aps Major Business
Table 147. Subcuject Aps Self-administered Parenteral Product and Services
Table 148. Subcuject Aps Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Subcuject Aps Recent Developments/Updates
Table 150. Subcuject Aps Competitive Strengths & Weaknesses
Table 151. Ascendia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. Ascendia Pharmaceuticals Major Business
Table 153. Ascendia Pharmaceuticals Self-administered Parenteral Product and Services
Table 154. Ascendia Pharmaceuticals Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Ascendia Pharmaceuticals Recent Developments/Updates
Table 156. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 157. West Pharmaceutical Services, Inc. Major Business
Table 158. West Pharmaceutical Services, Inc. Self-administered Parenteral Product and Services
Table 159. West Pharmaceutical Services, Inc. Self-administered Parenteral Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 160. Global Key Players of Self-administered Parenteral Upstream (Raw Materials)
Table 161. Self-administered Parenteral Typical Customers
Table 162. Self-administered Parenteral Typical Distributors
LIST OF FIGURE
Figure 1. Self-administered Parenteral Picture
Figure 2. World Self-administered Parenteral Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Self-administered Parenteral Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 5. World Self-administered Parenteral Average Price (2019-2030) & (US$/Unit)
Figure 6. World Self-administered Parenteral Production Value Market Share by Region (2019-2030)
Figure 7. World Self-administered Parenteral Production Market Share by Region (2019-2030)
Figure 8. North America Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 9. Europe Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 10. China Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 11. Japan Self-administered Parenteral Production (2019-2030) & (K Units)
Figure 12. Self-administered Parenteral Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 15. World Self-administered Parenteral Consumption Market Share by Region (2019-2030)
Figure 16. United States Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 17. China Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 18. Europe Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 19. Japan Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 20. South Korea Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 22. India Self-administered Parenteral Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Self-administered Parenteral by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Self-administered Parenteral Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Self-administered Parenteral Markets in 2023
Figure 26. United States VS China: Self-administered Parenteral Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Self-administered Parenteral Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Self-administered Parenteral Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Self-administered Parenteral Production Market Share 2023
Figure 30. China Based Manufacturers Self-administered Parenteral Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Self-administered Parenteral Production Market Share 2023
Figure 32. World Self-administered Parenteral Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Self-administered Parenteral Production Value Market Share by Type in 2023
Figure 34. Pre-filled Syringes
Figure 35. Autoinjectors
Figure 36. Pen Injectors
Figure 37. Others
Figure 38. World Self-administered Parenteral Production Market Share by Type (2019-2030)
Figure 39. World Self-administered Parenteral Production Value Market Share by Type (2019-2030)
Figure 40. World Self-administered Parenteral Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Self-administered Parenteral Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Self-administered Parenteral Production Value Market Share by Application in 2023
Figure 43. Pharmacy
Figure 44. Online Sales
Figure 45. Other
Figure 46. World Self-administered Parenteral Production Market Share by Application (2019-2030)
Figure 47. World Self-administered Parenteral Production Value Market Share by Application (2019-2030)
Figure 48. World Self-administered Parenteral Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Self-administered Parenteral Industry Chain
Figure 50. Self-administered Parenteral Procurement Model
Figure 51. Self-administered Parenteral Sales Model
Figure 52. Self-administered Parenteral Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
